Hodgkin's Disease
- 25 February 1993
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 328 (8) , 560-565
- https://doi.org/10.1056/nejm199302253280808
Abstract
Radiotherapy is curative for localized Hodgkin's disease,1,2 and there is now general agreement that advanced Hodgkin's disease can be cured by chemotherapy. This opinion is bolstered by the 20-year survival experience of the original group of patients treated with combination chemotherapy at the National Cancer Institute (Figure 1) and by experience with other regimens (Table 1)29.Therapy According to Disease StageDisease stage is the principal factor in selecting treatment for patients with Hodgkin's disease. The Ann Arbor system of classification is shown in Table 22. Although they are far outweighed by the benefits of successful treatment, there . . .Keywords
This publication has 50 references indexed in Scilit:
- Chemotherapy of Advanced Hodgkin's Disease with MOPP, ABVD, or MOPP Alternating with ABVDNew England Journal of Medicine, 1992
- Ch1VPP—An Effective and Well-Tolerated Alternative to MOPP Therapy for Hodgkinʼs DiseaseAmerican Journal of Clinical Oncology, 1988
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASEThe Lancet, 1987
- Concomitant illness in patients treated for Hodgkin's diseaseCancer Treatment Reviews, 1986
- Alternating Drug Combinations in the Treatment of Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1982
- The treatment of stage IIIa hodgkin's disease: What is the role of combined modality therapy?International Journal of Radiation Oncology*Biology*Physics, 1978
- MVPP chemotherapy regimen for advanced Hodgkin's diseaseBMJ, 1978
- Hematologic Neoplasia in Patients Treated for Hodgkin's DiseaseNew England Journal of Medicine, 1977
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975